ATE251640T1 - Neues chondrozytprotein - Google Patents

Neues chondrozytprotein

Info

Publication number: ATE251640T1
Authority: AT; Austria
Prior art keywords: chondrocytes; protein; cartilaginous; control; found
Prior art date: 1993-07-23

Application number

AT94111218T

Other languages

English (en)

Inventor

Yukio Kato

Haiou Pan

Kazuyuki Doi

Original Assignee

Kato Yukio Prof

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-23

Filing date

1994-07-19

Publication date

2003-10-15

1994-07-19 Application filed by Kato Yukio Prof filed Critical Kato Yukio Prof

2003-10-15 Application granted granted Critical

2003-10-15 Publication of ATE251640T1 publication Critical patent/ATE251640T1/de

Links

210000001612 chondrocyte Anatomy 0.000 title abstract 5
102000004169 proteins and genes Human genes 0.000 title abstract 3
108090000623 proteins and genes Proteins 0.000 title abstract 3
102000014914 Carrier Proteins Human genes 0.000 abstract 1
108010062580 Concanavalin A Proteins 0.000 abstract 1
102000005744 Glycoside Hydrolases Human genes 0.000 abstract 1
108010031186 Glycoside Hydrolases Proteins 0.000 abstract 1
208000029725 Metabolic bone disease Diseases 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
238000004458 analytical method Methods 0.000 abstract 1
108091008324 binding proteins Proteins 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
230000004069 differentiation Effects 0.000 abstract 1
208000030159 metabolic disease Diseases 0.000 abstract 1
230000011164 ossification Effects 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biomedical Technology (AREA)
Analytical Chemistry (AREA)
Hematology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Biotechnology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT94111218T 1993-07-23 1994-07-19 Neues chondrozytprotein ATE251640T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP18233893		1993-07-23

Publications (1)

Publication Number	Publication Date
ATE251640T1 true ATE251640T1 (de)	2003-10-15

Family

ID=16116566

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94111218T ATE251640T1 (de)	1993-07-23	1994-07-19	Neues chondrozytprotein

Country Status (7)

Country	Link
US (1)	US5607920A (de)
EP (1)	EP0635518B1 (de)
KR (1)	KR950003312A (de)
AT (1)	ATE251640T1 (de)
AU (1)	AU687407B2 (de)
CA (1)	CA2128647A1 (de)
DE (1)	DE69433221T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5858689A (en) *	1993-07-22	1999-01-12	Ludwig Institute For Cancer Research	Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof
US6008013A (en) *	1996-07-05	1999-12-28	University Of Rochester	Chondrocyte proteins
US6312952B1 (en)	1999-05-27	2001-11-06	The Research Foundation Of State University Of New York	In vitro cell culture device including cartilage and methods of using the same
WO2001013951A1 (fr) *	1999-08-19	2001-03-01	Chugai Seiyaku Kabushiki Kaisha	Promoteurs de chondrogenese
US8697139B2 (en)	2004-09-21	2014-04-15	Frank M. Phillips	Method of intervertebral disc treatment using articular chondrocyte cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3626414C2 (de) *	1986-08-05	1994-11-10	Robapharm Ag	Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
JPH05178896A (ja) *	1990-08-23	1993-07-20	Mitsubishi Kasei Corp	新規なタンパク質、それをコードする遺伝子及びその産生方法

1994
- 1994-07-19 AT AT94111218T patent/ATE251640T1/de not_active IP Right Cessation
- 1994-07-19 EP EP94111218A patent/EP0635518B1/de not_active Expired - Lifetime
- 1994-07-19 DE DE69433221T patent/DE69433221T2/de not_active Expired - Fee Related
- 1994-07-21 US US08/278,617 patent/US5607920A/en not_active Expired - Fee Related
- 1994-07-21 AU AU68602/94A patent/AU687407B2/en not_active Ceased
- 1994-07-22 CA CA002128647A patent/CA2128647A1/en not_active Abandoned
- 1994-07-22 KR KR1019940017741A patent/KR950003312A/ko not_active Ceased

Also Published As

Publication number	Publication date
US5607920A (en)	1997-03-04
DE69433221D1 (de)	2003-11-13
EP0635518B1 (de)	2003-10-08
EP0635518A1 (de)	1995-01-25
CA2128647A1 (en)	1995-01-24
AU6860294A (en)	1995-02-02
KR950003312A (ko)	1995-02-16
DE69433221T2 (de)	2004-07-29
AU687407B2 (en)	1998-02-26

Similar Documents

Publication	Publication Date	Title
BR1100321A (pt)	2000-03-21	Polipetìdeo utilizável como elemento de imunogenia, agente imunogênio, composição útil para a prevenção e/ou para o tratamento das afecções provocadas pelo vrs, sequência nucleotìdica, processo de pre uma proteìna
ATE319827T1 (de)	2006-03-15	Polypeptid, das die differenzierung unterdrueckt
ES2160704T3 (es)	2001-11-16	Tratamiento del sindrome de insensibilidad parcial a la hormona de crecimiento.
LU90855I2 (en)	2002-01-24	Proteine 1 osteogenique recombinante humaine: bmp-7 et ses d-riv-s pharmaceutiquement acceptables
CA2259163A1 (en)	1998-01-29	Nt-3 and bdnf analogs having improved circulating life and/or absorption
NO20050998D0 (no)	2005-02-24	DNA som koder for et biologisk aktivt fragment av baktericid/premeabilitetsokende protein fremgangsmate for fremstilling av dette, samt farmasoytisk preparat inneholdende dette
IL136076A0 (en)	2001-05-20	Mammalian cytokin-like polypeptide -10
DE69333346D1 (de)	2004-01-22	Neuartiges p- selectin ligandenprotein
ATE127844T1 (de)	1995-09-15	Dns und ihre verwendung.
ATE404668T1 (de)	2008-08-15	Wachstumsfaktor-homologe zvegf-3
DE69130497D1 (de)	1998-12-24	Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
DE69429365D1 (de)	2002-01-17	Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
HU895788D0 (en)	1991-08-28	Process for producing peptides and medical products containing them
PH27403A (en)	1993-06-21	Polypeptides useful as lockers of calcium channel
ATE251640T1 (de)	2003-10-15	Neues chondrozytprotein
EP0515434A4 (en)	1993-06-16	Method for treating intestinal diseases
DE69434997D1 (de)	2007-08-16	Menschliches Chondromodulin-I-Protein
ES2012128A6 (es)	1990-03-01	Metodo de tratar plantas con acidos organicos que contienen azufre.
PT914148E (pt)	2003-12-31	Tratamento do sindroma de insensibilidade parcial a hormona de crescimento
ATE145939T1 (de)	1996-12-15	Mitogen für die glatte muskulatur und dessen kodierende dns
ES2129022T3 (es)	1999-06-01	Proteina condromodulina-i.
MX9800686A (es)	1998-10-31	Nueva proteina hmw humana mp52s.
EP0903147A3 (de)	2002-02-27	Verwendung eines REG-2 als Mitogene für Schwannzellen
RO116403B1 (ro)	2001-01-30	Derivaţi ai teofilinei şi teobrominei şi procedeu de preparare
ATE127018T1 (de)	1995-09-15	Pharmazeutische zusammensetzung mit antiviraler und antibakterieller wirkung.

Legal Events

Date	Code	Title	Description
2004-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties